Literature DB >> 32717176

Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Na Li1,2,3, Bianca J J M Brundel4.   

Abstract

Atrial fibrillation (AF), the most common progressive and age-related cardiac arrhythmia, affects millions of people worldwide. AF is associated with common risk factors, including hypertension, diabetes mellitus, and obesity, and serious complications such as stroke and heart failure. Notably, AF is progressive in nature, and because current treatment options are mainly symptomatic, they have only a moderate effect on prevention of arrhythmia progression. Hereto, there is an urgent unmet need to develop mechanistic treatments directed at root causes of AF. Recent research findings indicate a key role for inflammasomes and derailed proteostasis as root causes of AF. Here, we elaborate on the molecular mechanisms of these 2 emerging key pathways driving the pathogenesis of AF. First the role of NLRP3 (NACHT, LRR, and PYD domains-containing protein 3) inflammasome on AF pathogenesis and cardiomyocyte remodeling is discussed. Then we highlight pathways of proteostasis derailment, including exhaustion of cardioprotective heat shock proteins, disruption of cytoskeletal proteins via histone deacetylases, and the recently discovered DNA damage-induced nicotinamide adenine dinucleotide+ depletion to underlie AF. Moreover, potential interactions between the inflammasomes and proteostasis pathways are discussed and possible therapeutic targets within these pathways indicated.

Entities:  

Keywords:  DNA damage; atrial fibrillation; histone deacetylases; inflammasomes; inflammation; proteostasis

Year:  2020        PMID: 32717176      PMCID: PMC7388703          DOI: 10.1161/CIRCRESAHA.119.316364

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  182 in total

1.  Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress.

Authors:  Dao-Fu Dai; Edward J Hsieh; Yonggang Liu; Tony Chen; Richard P Beyer; Michael T Chin; Michael J MacCoss; Peter S Rabinovitch
Journal:  Cardiovasc Res       Date:  2011-10-19       Impact factor: 10.787

Review 2.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

3.  Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation.

Authors:  B J Brundel; I C Van Gelder ; R H Henning; R G Tieleman; A E Tuinenburg; M Wietses; J G Grandjean; W H Van Gilst ; H J Crijns
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

4.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

5.  Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease.

Authors:  Ying Luan; Yuanyuan Guo; Shufeng Li; Bo Yu; Sui Zhu; Shaojun Li; Ning Li; Zhen Tian; Chenghai Peng; Jiali Cheng; Qingsong Li; Jinjin Cui; Ye Tian
Journal:  Europace       Date:  2010-09-10       Impact factor: 5.214

6.  Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis.

Authors:  Na Wu; Bin Xu; Ying Xiang; Long Wu; Yao Zhang; Xiangyu Ma; Shifei Tong; Maoqing Shu; Zhiyuan Song; Yafei Li; Li Zhong
Journal:  Int J Cardiol       Date:  2013-09-08       Impact factor: 4.164

7.  The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.

Authors:  Atsuko Nakai; Osamu Yamaguchi; Toshihiro Takeda; Yoshiharu Higuchi; Shungo Hikoso; Masayuki Taniike; Shigemiki Omiya; Isamu Mizote; Yasushi Matsumura; Michio Asahi; Kazuhiko Nishida; Masatsugu Hori; Noboru Mizushima; Kinya Otsu
Journal:  Nat Med       Date:  2007-04-22       Impact factor: 53.440

Review 8.  Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review.

Authors:  Jakeline Rheinheimer; Bianca M de Souza; Natali S Cardoso; Andrea C Bauer; Daisy Crispim
Journal:  Metabolism       Date:  2017-06-11       Impact factor: 8.694

9.  High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation.

Authors:  Qiwen Xu; Lin Bo; Jiaxin Hu; Jin Geng; Yuhan Chen; Xuelin Li; Fu Chen; Jie Song
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

10.  Interactive domains in the molecular chaperone human alphaB crystallin modulate microtubule assembly and disassembly.

Authors:  Joy G Ghosh; Scott A Houck; John I Clark
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

View more
  21 in total

1.  Expression and predictive value of NLRP3 in patients with atrial fibrillation and stroke.

Authors:  Jue Sun; Jiayi Xu; Qianhong Yang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  Introduction to the Compendium on Atrial Fibrillation, and a Few Thoughts Along The Way….

Authors:  Patrick T Ellinor
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

3.  NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.

Authors:  Larry Scott; Anke C Fender; Arnela Saljic; Luge Li; Xiaohui Chen; Xiaolei Wang; Dominik Linz; Jilu Lang; Mathias Hohl; Darragh Twomey; Thuy T Pham; Rodrigo Diaz-Lankenau; Mihail G Chelu; Markus Kamler; Mark L Entman; George E Taffet; Prashanthan Sanders; Dobromir Dobrev; Na Li
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

Review 4.  The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation.

Authors:  Xiaolei Wang; Xiaohui Chen; Dobromir Dobrev; Na Li
Journal:  Pflugers Arch       Date:  2021-01-28       Impact factor: 3.657

Review 5.  Comprehensive evaluation of electrophysiological and 3D structural features of human atrial myocardium with insights on atrial fibrillation maintenance mechanisms.

Authors:  Aleksei V Mikhailov; Anuradha Kalyanasundaram; Ning Li; Shane S Scott; Esthela J Artiga; Megan M Subr; Jichao Zhao; Brian J Hansen; John D Hummel; Vadim V Fedorov
Journal:  J Mol Cell Cardiol       Date:  2020-10-29       Impact factor: 5.000

6.  Cannabinoid Receptor Agonist Inhibits Atrial Electrical Remodeling in a Tachypaced Ex Vivo Rat Model.

Authors:  Danielle I Lee; Michael Murninkas; Sigal Elyagon; Yoram Etzion; Hope D Anderson
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

7.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

Review 8.  Emerging Antiarrhythmic Drugs for Atrial Fibrillation.

Authors:  Arnela Saljic; Jordi Heijman; Dobromir Dobrev
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

9.  Identifying ceRNA Networks Associated With the Susceptibility and Persistence of Atrial Fibrillation Through Weighted Gene Co-Expression Network Analysis.

Authors:  Yaozhong Liu; Na Liu; Fan Bai; Qiming Liu
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

Review 10.  Global trends and prospects about inflammasomes in stroke: a bibliometric analysis.

Authors:  Junjun Yin; Jiayang Wan; Jiaqi Zhu; Guoying Zhou; Yuming Pan; Huifen Zhou
Journal:  Chin Med       Date:  2021-07-07       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.